Buprenorphine Inductions via Transdermal Patches for Opioid Use Disorder in the Inpatient Setting
J Pain Palliat Care Pharmacother. 2023 Jun 16:1-6. doi: 10.1080/15360288.2023.2222021. Online ahead of print.ABSTRACTBuprenorphine inductions traditionally require an opioid-free period due to the risk of precipitated opioid withdrawal. Hospitalized patients with opioid use disorder and concurrent acute pain may be eligible for buprenorphine therapy. However, effective buprenorphine induction strategies in this patient population have not been well established. Investigators sought to review the completion of a low dose induction protocol that does not require an opioid-free period prior to buprenorphine initiation. Hospit...
Source: Journal of Pain and Palliative Care Pharmacotherapy - June 16, 2023 Category: Palliative Care Authors: Hollie Porras Elizabeth Johnson Mariya Kotova James Chenoweth Daniel Colby Source Type: research